Industry experts from across 100 countries will descend on Riyadh this December for launch event of most comprehensive pharma ...

Qu – which, according to Parsa, is the fruit of a collaboration between a global team of experienced AI scientists, ...

This report was born out of comprehensive reader research, revealing an increasing appetite for this type of publication ...

a formulation development services company with a wealth of experience in comprehensive pharmaceutical drug development, have forged a strategic partnership to accelerate drug development for global ...

Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Good day, ladies and gentlemen, and welcome to Repligen ...

Bayer reported a decline of 37% in earnings per share on Tuesday, which sent its stock down 12%. CEO Bill Anderson urged investors to be patient as the company executes on a performance-boosting ...

This new strategic alliance builds on CMTA's long-standing support ... and provide crucial tools that accelerate therapies ...

Revenue: Revenue for the three months ended September 30, 2024, increased to approximately $1,958,000 compared to $397,000 ...

Third quarter results highlight strong operational performance across key value drivers: YUPELRI® (revefenacin) net sales of $62.2 million, recognized by Viatris ...

The cash will be used to boost the company's research and development, as well as its manufacturing footprint in the U.S. The ...

Gilero, a medical device manufacturer with two sites in North Carolina, is expanding to a third site in the state -- a new 60 ...

By volume, Report Ocean estimated the Global Carboxymethyl Cellulose (CMC) Market size at 200.9 million tons in 2023. During the forecast period between 2024 and 2030, Report Ocean expects the Global ...